Navigation Links
EuroPCR 2014 examines vascular response and long-term safety of bioresorbable scaffolds
Date:5/22/2014

22 May 2014, Paris, France: At EuroPCR 2014 yesterday, experts discussed the development in evidence for bioresorbable vascular scaffolds, which represent an era of vascular restoration in interventional cardiology. The available data were analysed and participants heard that bioresorbable fixed strut vascular scaffolds are associated with increased acute thrombogenicity due to flow disturbances. This means that patients who are implanted with these devices need to receive ongoing dual antiplatelet therapy, and the strategy is under discussion. The panellists also pointed out that endothelialisation is further delayed when these devices are used compared with when thin strut drug-eluting stents are used.

Tan Huay Cheem, National University Heart Centre, Singapore, said: I think one of the greatest attractions of bioresorbable vascular scaffolds is the idea that normal vasofunction will eventually be restored. There is some evidence from imaging data to show that the plaque is modified alongside the stent dissolving. There is also positive remodelling taking place, and this vascular response is one of the most exciting aspects of the technology.

The diversity of devices that are approaching the market was also emphasised. Michael Joner, CEO, CVPath Institute, Gaithersburg, USA, said: There is no uniformity in these devices and no class effect. Every device needs to be assessed carefully and individually. The inflammatory response associated with these devices depends on the pace of degradation, so we need to assess how they degrade over time, and this has important implications for patient safety.

The long-term safety of bioresorbable vascular scaffolds will depend on various things: if we can see that arterial healing occurs over time; if full degradation occurs in the absence of excess inflammation and if we do not see too much positive remodelling, then these devices can be very beneficial to patient care, Joner added.

I think the technology i
'/>"/>

Contact: Isabelle Uzielli
iuzielli@europcr.com
EuroPCR
Source:Eurekalert

Page: 1 2

Related medicine news :

1. CRF will Provide updates on several key cardiovascular trials at EuroPCR
2. New ESC-EACTS guidelines on myocardial revascularization to be released at EuroPCR 2014
3. EuroPCR 2014 showcases technological advances in complex cardiovascular interventions
4. Personalizing revascularization strategy for STEMI patients is vital, EuroPCR panel finds
5. EuroPCR 2014 examines whether science translates into practice with new session format
6. Study examines medicare use for Mohs micrographic surgery and surgical excision for skin cancer
7. Study examines drug regimen for the treatment of non-small cell lung cancer among older patients
8. Study examines adverse effects among different radiation therapies for prostate cancer
9. LA BioMeds Dr. John Tsuang examines effects of Ibudilast and metamphetamines
10. Study examines benefit of follow-up CT when abdominal ultrasound inconclusive
11. Research examines when benefits of screening mammography outweigh the harms for women in their 40s
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... ... July 07, 2015 , ... ... today announced that TimberNook ( http://www.timbernook.com/ ) has selected the agency ... and marketing launch package for new camp providers. TimberNook is a nature-based ...
(Date:7/7/2015)... ... July 07, 2015 , ... Isabel Healthcare ... announced a partnership focused on providing knowledge organizing and differential diagnostic support tools ... be conducted with NIWH trained patient health educators, utilizing the Knowledge Organizer and ...
(Date:7/7/2015)... MO (PRWEB) , ... July 07, 2015 , ... ... liability law announce the launch of their new website, the Invokana Ketoacidosis ... Invokana FDA warning*, and serves as a resource for persons wishing to learn ...
(Date:7/7/2015)... ... 2015 , ... CareSync proudly announces today that Amy Gleason, ... House as a “Champion of Change” for Precision Medicine on Wednesday, July 8th. ... Change program recognizes Gleason and eight other extraordinary individuals who are making great ...
(Date:7/6/2015)... ... 07, 2015 , ... Currently, mobile testing is one the ... in the molecular diagnostic technologies, wide availability of immunosuppressive drugs and bioterrorism threats ... genetic engineering also open lucrative opportunities for the market players. , However, there ...
Breaking Medicine News(10 mins):Health News:TimberNook Selects Calypso Communications for PR, Social Media and Content Strategy 2Health News:Isabel Healthcare and the National Institute of Whole Health Announce Partnership for a Pilot Study Using the Isabel Diagnostic Support Tool and Knowledge Organizer 2Health News:Isabel Healthcare and the National Institute of Whole Health Announce Partnership for a Pilot Study Using the Isabel Diagnostic Support Tool and Knowledge Organizer 3Health News:National Attorneys Launch Invokana Ketoacidosis Lawsuit Center 2Health News:National Attorneys Launch Invokana Ketoacidosis Lawsuit Center 3Health News:White House names Champions of Change for Precision Medicine: CareSync COO Recognized 2Health News:White House names Champions of Change for Precision Medicine: CareSync COO Recognized 3Health News:World Infectious Disease Testing Market Examined by VPGMarketResearch.com in In-Demand Report Available at MarketPublishers.com 2Health News:World Infectious Disease Testing Market Examined by VPGMarketResearch.com in In-Demand Report Available at MarketPublishers.com 3
... , IRVINE, Calif., Aug. 25 CorVel ... Company,s Board of Directors has approved a 1,000,000 share expansion to ... approved for repurchase over the life of the program to 14,150,000 ... repurchase program in the fall of 1996. From the program,s inception ...
... New Single ... People to Sign Up to Donate Life - New CD - No Regrets In Stores ... Beverly Hills, ... smash with the song "I Swear," is returning to recording and performing after a seven-year ...
... , ROCKVILLE, Md., Aug. 25 ... for patients on behalf of both countries, the U.S. Pharmacopeial ... the United Mexican States (FEUM) today agreed to collaborate on ... key component of public health, helping to ensure the identity, ...
... , , , ... national nonprofit organization that helps people reclaim their lives from ... Foundation Relations. , , (Logo: http://www.newscom.com/cgi-bin/prnh/20061128/CGTU038LOGO ... "I,m very pleased to announce the appointment of William ...
... visitors to Indian subcontinent, CDC reports , TUESDAY, Aug. ... common cause of infection with an antimicrobial-resistant strain of ... new study finds. , About 300 cases of typhoid ... and the majority of these cases are associated with ...
... gender may be to blame, researchers say , TUESDAY, Aug. ... than men in the 30 days after a heart attack, ... new study finds. , Rather, "the difference can be attributed ... the presence of other illnesses, said study lead author Dr. ...
Cached Medicine News:Health News:CorVel Announces Expansion to Share Buyback Program 2Health News:CorVel Announces Expansion to Share Buyback Program 3Health News:R&B / Pop Vocal Quartet All-4-One Makes 7-Year Comeback 2Health News:R&B / Pop Vocal Quartet All-4-One Makes 7-Year Comeback 3Health News:Quality of Medicines Advanced by Agreement Between USP, Mexican Standards Body 2Health News:William C. Moyers Appointed Vice President of Foundation Relations for Hazelden 2Health News:International Travel Raises Risk of Typhoid 2Health News:Women More Prone to Die in Month After Heart Attack 2Health News:Women More Prone to Die in Month After Heart Attack 3
(Date:7/7/2015)... , July 7, 2015  PAREXEL International Corporation (NASDAQ: ... and Fiscal Year 2015 on Wednesday, August 5 th , ... will be available on PAREXEL,s website at www.PAREXEL.com ... PAREXEL will host a conference call and live webcast ... 2015 to discuss the results.  To access the webcast, visit ...
(Date:7/7/2015)... SHENZHEN, China , July 7, 2015 /PRNewswire/ -- ... ), a leading developer, manufacturer and marketer of ... to acquire the remaining stake in Wuhan Dragonbio ... million. Dragonbio is a domestic ... joint and other surgical products. Prior to today,s ...
(Date:7/7/2015)... , July 7, 2015 ... new generation of drugs within human and veterinary ... sales company in the United States ... Vet-CA1, its leading companion animal therapeutic. ... http://photos.prnewswire.com/prnh/20150703/228329 ) , Paccal ...
Breaking Medicine Technology:PAREXEL International Announces Date Of Fourth Quarter And Fiscal Year 2015 Earnings Release And Conference Call 2Mindray Medical to Acquire the Remaining Stake in Wuhan Dragonbio 2Mindray Medical to Acquire the Remaining Stake in Wuhan Dragonbio 3Mindray Medical to Acquire the Remaining Stake in Wuhan Dragonbio 4Oasmia Pharmaceutical Launches US Brand and Sales Platform 2
... Londe, M.D. Contributing Editor The outcome of many illnesses ... (ICUs) has not improved dramatically over the past decades, ... and pharmacological support of vital organ systems. Indeed, ... five days have a 20 percent risk of death ...
... level of blood oxygenation can be an essential ... in the clinical setting is often desirable. In ... technology into easily used point-of-care devices, recent products ... values., ,HemoCue, Inc., Lake Forest, Calif., says that ...
Cached Medicine Technology:Tight Glycemic Control in the ICU 2Tight Glycemic Control in the ICU 3Hemoglobin Testing at the Point of Care 2Hemoglobin Testing at the Point of Care 3
Replacement bulb for Vibratome light system....
These specialty razor blades are feather thin and very sharp. Most users have found an increased quality level in Vibratome sections with these blades....
The care package includes a spare motor, fuse, Spare Fluorescent Bulb, additional Vibratome Feather Blades, Specimen Adhesive, Specimen Mounting Blocks, and a Specimen Tray....
... The Specimen Tray accessory fits inside the existing ... working area for tissue sectioning. Specimens are ... tray. This is a great option if ... expensive buffer, or wish to utilize the black ...
Medicine Products: